Industries > Pharma > Cell-Based Assays World Industry and Market 2018-2028

Cell-Based Assays World Industry and Market 2018-2028

Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs

PUBLISHED: 18 September 2018
PAGES: 241
PRODUCT CODE: PHA0331
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0331 Categories: , Tags: ,

The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 85 tables and 103 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Cell-based Assays market forecasts from 2018-2028

• Cell-Based Assays Market by Product Type:
• Instrument
• Consumables
• Software
• Services
• Reagents
• Assay Kits
• Microplates
• Cell Lines
• Probes & Labels

• Cell-Based Assays Market by Application:
• Drug Discovery
• Basic Research
• Predictive Technology

• Cell-based Assays Market by End-User:
• Pharma & Biotech Companies
• Academic Institutes
• CROs

• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Japan
• Germany
• UK
• France
• Spain
• Italy
• China
• India
• Russia
• Brazil

• Our study includes SWOT and STEP analysis of the cell-based assays market.

• Our study discusses the selected leading companies that are the major players in the cell-based assays market:
• BD (Becton, Dickinson and Company)
• BioAgilytix Labs
• BioVision
• Cell Assay Innovations, Inc.
• Charles River Laboratories International
• CYTOO SA
• DiscoverX
• GE Healthcare
• InSphero
• Marin Biological Laboratories
• Molecular Devices
• Perkin Elmer
• Pharmaceutical Product Development
• Porsolt
• Promega
• ProQinase GmbH
• QGel
• SGS Group, Inc.
• Thermo Fisher Scientific (and Affymetrix acquisition)

Cell-Based Assays World Industry and Market 2018-2028

• This report also discusses technology, trends and future outlook of the cell-based assays industry

Visiongain’s study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.

Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays World Industry and Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays World Industry and Market 2018-2028


Latest Pharma news

“Global Ophthalmic Drugs market set to grow to $32bn by 2024” says Visiongain report

Successful harnessing of the opportunities for growth in the ophthalmic pharmaceuticals market will depend upon the development of novel products with technologies that increase clinical effectiveness and development of products for previously-untreated ophthalmic conditions.

15 August 2019

READ

“Global Medical Device Contract Manufacturing market set to grow to $130bn by 2024” says new Visiongain report

The available reduced costs of outsourced manufacturing combined with access to the innovation power of CMOs are major drivers behind the decision to outsource manufacturing processes.

06 August 2019

READ

“3D Printing for Healthcare market is worth $872 million in 2019” says Visiongain report

The main appeal of 3D printed healthcare products to professionals is that each unit can be personalised to fit the recipient.

02 August 2019

READ

“Global Rare Disease Drugs market set to grow to $257bn by 2024” says new Visiongain report

It is difficult to investigate rare diseases as the pool of patients is very small and often results in inadequate clinical knowledge.

01 August 2019

READ

Categories

Category